LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Elanco Animal Health Inc

Cerrado

SectorSanidad

23.37 -2.34

Resumen

Variación precio

24h

Actual

Mínimo

22.91

Máximo

23.44

Métricas clave

By Trading Economics

Ingresos

-198M

-232M

Ventas

7M

1.1B

P/B

Media del Sector

372.714

66.845

Margen de beneficios

-20.28

Empleados

9,400

EBITDA

-172M

6M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+20.86% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

666M

13B

Apertura anterior

25.71

Cierre anterior

23.37

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

123 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Elanco Animal Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 may 2025, 11:29 UTC

Adquisiciones, fusiones, absorciones

Elanco Sells Non-Core Asset to Blackstone for $295 Million

5 may 2025, 11:14 UTC

Adquisiciones, fusiones, absorciones

Elanco Sells Non-Core Asset to Blackstone for $295 Mln

5 may 2025, 10:50 UTC

Adquisiciones, fusiones, absorciones

Elanco Animal Health: Monetization of This Non-Core Asset Will Be Used to Accelerate Debt Reduction >ELAN

5 may 2025, 10:49 UTC

Adquisiciones, fusiones, absorciones

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone for $295M

Comparación entre iguales

Cambio de precio

Elanco Animal Health Inc previsión

Precio Objetivo

By TipRanks

20.86% repunte

Estimación a 12 Meses

Media 28.91 USD  20.86%

Máximo 32 USD

Mínimo 24 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Elanco Animal Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

11

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

9.77 / N/ASoporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

123 / 351 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.